Predictors of mid-term outcomes in patients undergoing implantation of a ventricular assist device directly after extracorporeal life support

Keebler, 2018, Venoarterial extracorporeal membrane oxygenation in cardiogenic shock, JACC Heart Fail, 6, 503, 10.1016/j.jchf.2017.11.017

Muslem, 2017, Effect of age and renal function on survival after left ventricular assist device implantation, Am J Cardiol, 120, 2221, 10.1016/j.amjcard.2017.08.045

Mohamedali, 2017, The influence of pre-left ventricular assist device (LVAD) implantation glomerular filtration rate on long-term LVAD outcomes, Heart Lung Circ, 26, 1216, 10.1016/j.hlc.2017.01.002

Majumder, 2017, Impact of postoperative liver dysfunction on survival after left ventricular assist device implantation, Ann Thorac Surg, 104, 1556, 10.1016/j.athoracsur.2017.04.048

Volkovicher, 2018, Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation, J Artif Organs, 21, 31, 10.1007/s10047-017-0988-z

Magnussen, 2018, Gender differences and outcomes in left ventricular assist device support: the European Registry for Patients with Mechanical Circulatory Support, J Heart Lung Transplant, 37, 61, 10.1016/j.healun.2017.06.016

Teigen, 2017, Preoperative pectoralis muscle quantity and attenuation by computed tomography are novel and powerful predictors of mortality after left ventricular assist device implantation, Circ Heart Fail, 10, 10.1161/CIRCHEARTFAILURE.117.004069

Pabst, 2018, Predictors of survival for nonhighly selected patients undergoing resuscitation with extracorporeal membrane oxygenation after cardiac arrest, ASAIO J, 64, 368, 10.1097/MAT.0000000000000644

Pitsis, 2006, First human implantation of a new rotary blood pump: design of the clinical feasibility study, Hellenic J Cardiol, 47, 368

Annamalai, 2017, Predictors of mortality in the critically ill cirrhotic patient: is the model for end-stage liver disease enough?, J Am Coll Surg, 224, 276, 10.1016/j.jamcollsurg.2016.11.005

Critsinelis, 2018, MELD-XI scoring system to predict outcomes in patients who undergo LVAD implantation, Ann Thorac Surg, 106, 513, 10.1016/j.athoracsur.2018.02.082

Freundt, 2017, Impact of dynamic changes of elevated bilirubin on survival in patients on veno-arterial extracorporeal life support for acute circulatory failure, PLoS One, 12, e0184995, 10.1371/journal.pone.0184995

Maxhera, 2014, Survival predictors in ventricular assist device patients with prior extracorporeal life support: selecting appropriate candidates, Artif Organs, 38, 727, 10.1111/aor.12386

Lebreton, 2015, Extracorporeal life support as a bridge to bridge: a strategy to optimize ventricular assist device results, Eur J Cardiothorac Surg, 48, 785, 10.1093/ejcts/ezu516

Blandino Ortiz, 2017, Altered liver function in patients undergoing veno-arterial extracorporeal membrane oxygenation (ECMO) therapy, Minerva Anestesiol, 83, 255, 10.23736/S0375-9393.16.11442-7

Sern Lim, 2016, Baseline MELD-XI score and outcome from veno-arterial extracorporeal membrane oxygenation support for acute decompensated heart failure, Eur Heart J Acute Cardiovasc Care, 5, 82, 10.1177/2048872615610865

Shiga, 2011, Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation, Circ J, 75, 121, 10.1253/circj.CJ-10-0770

Roth, 2016, Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery, Crit Care, 20, 57, 10.1186/s13054-016-1242-4

Blumer, 2018, Sex-specific outcome disparities in patients receiving continuous-flow left ventricular assist devices: a systematic review and meta-analysis, ASAIO J, 64, 440, 10.1097/MAT.0000000000000695

Weymann, 2015, Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis, Artif Organs, 39, 212, 10.1111/aor.12361

Han, 2018, Different clinical course and complications in interagency registry for mechanically assisted circulatory support 1 (INTERMACS) patients managed with or without extracorporeal membrane oxygenation, ASAIO J, 64, 318, 10.1097/MAT.0000000000000674

Pavasini, 2017, Extracorporeal circulatory support in acute coronary syndromes: a systematic review and meta-analysis, Crit Care Med, 45, e1173, 10.1097/CCM.0000000000002692

Smith, 2017, Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry, Crit Care, 21, 45., 10.1186/s13054-017-1633-1

Dangers, 2017, Extracorporeal membrane oxygenation for acute decompensated heart failure, Crit Care Med, 45, 1359, 10.1097/CCM.0000000000002485

Liao, 2017, The prognostic risk factors of ECMO in patients with cardiogenic shock: a retrospective cohort analysis, Heart Surg Forum, 20, 10.1532/hsf.1780

Slottosch, 2017, Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock, J Crit Care, 42, 35, 10.1016/j.jcrc.2017.06.022

Swol, 2017, Effect of body mass index on the outcome of surgical patients receiving extracorporeal devices (VV ECMO, pECLA) for respiratory failure, Int J Artif Organs, 45, 532

Musci, 2008, Body mass index and outcome after ventricular assist device placement, Ann Thorac Surg, 86, 1236, 10.1016/j.athoracsur.2008.05.044

Lee, 2016, Associations with 30-day survival following extracorporeal membrane oxygenation in patients with acute ST segment elevation myocardial infarction and profound cardiogenic shock, Heart Lung, 45, 532, 10.1016/j.hrtlng.2016.08.006

Kirklin, 2017, Eighth annual INTERMACS report: special focus on framing the impact of adverse events, J Heart Lung Transplant, 36, 1080, 10.1016/j.healun.2017.07.005